U.S. Cardiovascular Ultrasound Market Size & Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiovascular ultrasound market will help companies and investors design strategic landscapes.

Transthoracic echocardiography was the largest segment with a revenue share of 55.38% in 2023. Horizon Databook has segmented the U.S. cardiovascular ultrasound market based on transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, other types covering the revenue growth of each sub-segment from 2018 to 2030.

Growing prevalence of heart diseases and increasing percentage of GDP being invested in public healthcare are some of the major factors driving the market growth in the country. According to CDC, around 735,000 Americans have a heart attack every year, out of which 525,000 people experience it for the first time and the rest 210,000 occur in people who have already had an attack. This highlights the scope for growth of CVUS equipment.

The highest usage of echocardiography in hospitals is observed along the east coast of the U.S. When evaluated on a state-by-state basis, New York, Rhode Island, and Montana were major users of inpatient echo technology, whereas Wyoming, Alaska, and New Mexico had the lowest rate. Growing adoption of echocardiography in the country is creating growth opportunity for market players to expand their product portfolios by launching CVUS devices.

For instance, in August 2020, Philips launched EPIQ CVx cardiovascular ultrasound system. This CVUS is built on the EPIQ ultrasound platform, which helps in increasing diagnostic confidence and simplifies clinicians workflow. It also helps in providing accurate information without frequent monitoring, thereby reducing the need for repeat scans. Moreover, in September 2020, the company also launched Affiniti CVx cardiovascular ultrasound system for providing enhanced care to patients by delivering effective systems.